发明名称 |
COMBINATION OF SGLT2 INHIBITOR AND ANTI-HYPERTENSION DRUG. |
摘要 |
<p>Provided is a medicinal agent or a treatment method, in which a combination of an SGLT2 inhibitor and an anti-hypertension drug is used, and which is useful for the treatment of such diseases that at least hypertension or diabetes is included as a risk factor for a cardiovascular event. According to the present invention, an excellent hypotensive effect, which cannot be achieved when an anti-hypertension drug is used alone, can be achieved. Therefore, the conventional problem of using at least two types of anti-hypertension drugs for achieving a desired hypotensive effect can be solved. Furthermore, the present invention exerts a significant therapeutic effect on diabetes, a diabetes-related disease or a diabetes complication, particularly diabetic nephropathy. Furthermore, the present invention is also useful for the treatment of a disease in which the renal function is deteriorated.</p> |
申请公布号 |
MX2015002572(A) |
申请公布日期 |
2015.06.05 |
申请号 |
MX20150002572 |
申请日期 |
2013.08.30 |
申请人 |
TAISHO PHARMACEUTICAL CO., LTD. |
发明人 |
TAKAHASHI, TEISUKE;KOJIMA, NAOKI;MIYATA, NORIYUKI;TOMOIKE, HIDEKI;TAKEDA, TAKUYA;ROMAN, RICHARD J. |
分类号 |
A61K45/06;A61K31/382;A61K31/401;A61K31/41;A61P9/12;A61P31/10 |
主分类号 |
A61K45/06 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|